Skip to main content

UIDAI barred Bharti Airtel and Airtel Payments Bank

In its strongest action yet, the UIDAI has temporarily barred Bharti Airtel and Airtel Payments Bank from conducting Aadhaar-based SIM verification of mobile customers using eKYC process as well as e-KYC of payments bank clients. The action follows allegations of Bharti Airtel using the Aadhaar-eKYC based SIM verification process to open payments bank accounts of its subscribers without their 'informed consent'. UIDAI also took strong objection to allegations that such payments bank accounts are being linked to receive LPG subsidy. UIDAI, in an interim order, "suspended e-KYC licence key of Bharti Airtel Ltd and Airtel Payment Bank Ltd with immediate effect," sources with direct knowledge of the development said. This essentially means Airtel would not be able to, in the interim, carry out 'electronic-verification' or link mobile SIMs of its customers with their 12-digit biometric national ID Aadhaar though the efficient and paperless eKYC (or electronic K...

Fundamental Analysis of Balaji Amines Ltd by Sameer S

Balaji Amines Ltd.is an ISO 9001: 2008 certified company, specialised in manufacturing Methylamines, Ethylamines, Derivatives of Specialty Chemicals and Natural Products. It also owns a 5 star Hotel in Solapur - Balaji Sarovar.

The company enjoys leadership position in many of its products like Monomethylamine (MMA), Dimethyl amine(DMA), Trimethylamine (TMA),DimethylAmino Ethanol (DMAE), Mono Methyl Amino Ethanol etc.

BAL`s state-of-the-art manufacturing facility is located at Tamalwadi Village, near Solapur (Maharashtra State, India) The facility is fully equipped with latest technology like digital computerized controlled systems, which facilitates the control of operations from the control room in addition, BAL possesses an excellent R&D facilities and laboratory, which helps in conducting basic research and also to fine tune the process.The company has in total three state of the art units, two near Solapur and one near Hyderabad.

The company has a very High market share of DMAHCL which is used in the making of Metaformin, a diabetic drug.

A lot of information about company, its products and history can be read from company website.

Financial Analysis :

1.  Sales Growth in past 10 years has been good at 13 % (218 crs to 668 crs). However the sales growth has declined in recent past (8% in last 5yrs and 3% in last 3 years). TTM sales growth is at 10% which is a good sign once again.

2. The OP margins are 17-21% range which is good. Since main RM are linked to crude so price fluctuation is expected. Apart from RM cost decline, the company has been continuously bringing in process efficiencies to increase the margins. The same can be read in company's latest AR.

Continuous R&D initiatives have resulted in excellent results during the year with improved consumption co-efficiencies of raw materials, utilities and utilization of resources. Your company has become one of the leaders in Specialty Chemicals in the International Specialty Chemical arena and plans to be on the top of the table in the years to come in India.

3. RM cost as percentage of sales has come down to 51.82% from past leading to higher margins recently.

4. The PAT has grown at healthy rate of 23% in last 10 years. The current NPM > 10% is once again a good sign.

5. The company has been consistently paying out tax at corporate rate of  33-34 % which is again a good sign.

6. The interest coverage stands at a healthy number of 9.8 which is again a good sign. The company has enough coverage during times of distress

7. The total leverage (Debt to equity) has been consistently brought down from 1.5 to 0.3 which means less interest outgo for the company for subsequent years.

8. The Cumulative PAT for last 10 years is 359 crores as against the cCFO of 541 crores. This indicates that company has been able to convert its net Profits to cash in a healthy fashion.

9. The company has generated FCF of around Rs 169 crores in last 10 years. The FCF as % of CFO during last ten years stands at 31%.

10. Total earnings retained in last 10 years is 326 crores and total market cap increase is 968 crores. 

In a nutshell the company has been doing absolutely fine on a Financial basis for last 10 years based on all of the above parameters.

Valuation Analysis :

The company is available at Market cap of 1046 crores with TTM PAT of 82 crores. The current P/E stands at 12.7 and which boils down to an earning yield of 7.8 % which is good and has decent MOS built in .

The company has been on an average has been paying out 10% of its profits as dividends during last 10 years which again is good sign.

Management Analysis :

The company is promoted by Mr A Prathap Reddy. He started the company operations in 1988.
His impeccable entrepreneurial skills, endurance and passion has brought glory to the firm, making BAL one of the leading manufacturers and exporters of specialty chemicals, aliphatic amines and derivatives in the chemical industry. For his remarkable contribution in this field, he has received an award in World Class Manufacturing and Operational Excellence for the year 2011 as well as in the Manufacturing Leadership Awards & Conclave 2012 instituted by the Industry 2.0 magazine.

The promoters hold 54.46% of the company,a slight increase over last one year. There is almost negligible Institutional or MF holdings in the company which is good for individual investor.

The total salary including commissions drawn by Directors and KMP is 14.21 crores which is the max allowed by act. I think this is on higher side and a negative for the company.

The management has been consistently adding value added products with higher margins year over year as can be seen from the latest AR.

The following R&D demonstration projects were undertaken during the year 2016-17:
1.Acetonitrile
2. Cartico Steroids
3. PVPK-90, Cross Povidone etc.
The results of these projects will be yielding fruits in the years to come.

The Company has 2 subsidiaries viz. Bhagyanagar Chemicals Ltd. a 100% subsidiary Company and Balaji Greentech Products Ltd. a substantially owned subsidiary.

Wherein, the undertaking of Bhagyanagar Chemicals Limited is limited to only a long term lease to its 100% holding company
Balaji Amines Limited who is carrying out manufacturing activity therein. As such the company Bhagyanagar Chemicals Limited
does not have any transactions except of lease rentals. Responsibility of safe keeping of the assets of the company vests with the holding company Balaji Amines Limited.

Balaji Greentech Products Limited (BGPL) is into manufacturing of energy efficient lamps and components. The company
manufactures, supplies a comprehensive range of Compact Fluorescent Lamps (CFL).

During the year, Company has initiated merger process of its subsidiaries as approved by the respective Boards. Present status of the merger is awaiting for NOC /approval of stock exchanges for the proposed merger.

Its very strange that company has been investing in Balaji Greentech products which owes BAL Rs 27 odd crores. The CFL business has been loosing money year over year. Again a negative on management part with poor capital allocation.

In the past it has been trying to sell off Balaji Greentech CFL business as can be read from web but the latest AR mention about merging the subsidiaries into parent.

The hotel business is atleast making money at EBIDTA level from 2016-17 and has good potential due to lack of similar hotels in Solapur area.

Business Outlook

BAL is a leading manufacturer of specialty and Fine chemicals and Amines and its derivatives. The Company’s exports have been increasing over the years and they stood around 17.75% of total sales. Over the years BAL has improved its performance both in value and volume growth.

Majority of customers are in the following Industrial verticals

1. PHARMA API’S
2. AGRO CHEMICALS
3. REFINERIES
4. WATER TREATMENT CHEMICALS & RUBBER CHEMICALS
5. LEATHER PROCESSING CHEMICALS
6. DYE STUFFS & PAINT INDUSTRY

Balaji amines looks like a decent company growing at a healthy rate while improving on the margins,value and profitability front. The only negatives are the promoters investment in subsidiaries which are loss making entities

Comments

Popular posts from this blog

Aditya Birla Capital vs L&T Finance

AB Capital is valued at nearly eight times book, L&T Finance holdings is available at five times book. On P/E basis the former is priced at 62 times trailing P/E while L&T finance is at 33 times. AB Capital has been growing at a CAGR of 30 per cent for some time, while L&T Fin holdings is on restructuring mode with 25 per cent growth in the last FY. On the range of businesses under their umbrella, A B Capital has many more than L&T Fin. While the former appears to be increasing the number of businesses it controls, the latter is now focused on just three verticals. While the Birlas are not known to exit businesses that are in trouble, the professional management of L&T Fin is more ruthless and focused on improving ROE. For instance, Birla Sunlife life insurance is steadily losing market share, but its unlikely AB Capital will sell the life insurance business. Same does not apply for L&T Fin.

Baby & SIP

1. Can we expect the baby to run after his/her birth ? - No 👉 Then why do we expect our newly started SIP should run immediately !! 2. How many times baby has fallen ill during 0-5 years ? - Many Times 👉 Then why do we get afraid by negative returns of SIP between 0-5 years !! 3. When Baby cries, mother feeds him. But When SIP cries ( Sensex Dow 20% ) why don't we invest more !! We must give time to grow our Baby & SIP.. Lets start the SIP ..

RULE of 72

What is Rule of 72? In personal finance, if you divide the number 72 by the rate of interest, you get to know the number of years it will take for you to double the money.. Eg: if the rate of interest is 9%, simply divide the number 72 by 9% and the answer is 8. Thus it will take 8 years to double your money if you invest at 9% p.a. rate of interest. INTEREST: We can use this rule in reverse to know the rate of interest needed to double your money to achieve your set goal. Eg: If you have 250k today and you need 500k in 5 years. Just divide the number 72 by 5, the answer is 14.41%. Thus you need a type of investment avenue, where you earn at least 14.41% p.a. as rate of interest/returns to double your investment amount in 5 years. INFLATION: This 'Rule 72' helps you to understand about inflation also. It helps you to calculate the amount of time it will take for inflation to make the real value of money half. Let's say present inflation is 5.5%. When you divide 72 by ...